Literature DB >> 21263075

Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.

Katja Dahlke1, Christiane D Wrann, Oliver Sommerfeld, Maik Sossdorf, Peter Recknagel, Svea Sachse, Sebastian W Winter, Andreas Klos, Gregory L Stahl, Yuanyuan Xu Ma, Ralf A Claus, Konrad Reinhart, Michael Bauer, Niels C Riedemann.   

Abstract

Complement activation represents a crucial innate defense mechanism to invading microorganisms, but there is an eminent lack of understanding of the separate contribution of the different complement activation pathways to the host response during sepsis. We therefore investigated different innate host immune responses during cecal ligation and puncture (CLP)-induced sepsis in mice lacking either the alternative (fD(-/-)) or classical (C1q(-/-)) complement activation pathway. Both knockout mice strains showed a significantly reduced survival and increased organ dysfunction when compared with control mice. Surprisingly, fD(-/-) mice demonstrated a compensated bacterial clearance capacity as control mice at 6 h post CLP, whereas C1q(-/-) mice were already overwhelmed by bacterial growth at this time point. Interestingly, at 24 h after CLP, fD(-/-) mice failed to clear bacteria in a way comparable to control mice. However, both knockout mice strains showed compromised C3 cleavage during sepsis. Investigating potential causes for this discrepancy, we were able to demonstrate that despite normal bacterial clearance capacity early during the onset of sepsis, fD(-/-) mice displayed increased inflammatory cytokine generation and neutrophil recruitment into lungs and blood when compared with both control- and C1q(-/-) mice, indicating a potential loss of control over these immune responses. Further in vitro experiments revealed a strongly increased Nf-κB activation capacity in isolated neutrophils from fD(-/-) mice, supporting this hypothesis. Our results provide evidence for the new concept that the alternative complement activation pathway exerts a distinctly different contribution to the innate host response during sepsis when compared with the classical pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263075      PMCID: PMC3512104          DOI: 10.4049/jimmunol.1002741

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.

Authors:  Olaf Neth; Dominic L Jack; Marina Johnson; Nigel J Klein; Malcolm W Turner
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

Review 2.  Novel strategies for the treatment of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  Nat Med       Date:  2003-05       Impact factor: 53.440

3.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

4.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 5.  The role of NF-kappaB in the regulation of cell stress responses.

Authors:  Tieli Wang; Xia Zhang; Jian Jian Li
Journal:  Int Immunopharmacol       Date:  2002-10       Impact factor: 4.932

6.  Complement activation after oxidative stress: role of the lectin complement pathway.

Authors:  C D Collard; A Väkevä; M A Morrissey; A Agah; S A Rollins; W R Reenstra; J A Buras; S Meri; G L Stahl
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

7.  Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury.

Authors:  J E Jordan; M C Montalto; G L Stahl
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

8.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Role for the alternative complement pathway in ischemia/reperfusion injury.

Authors:  Gregory L Stahl; Yuanyuan Xu; Liming Hao; Mendy Miller; Jon A Buras; Michael Fung; Hui Zhao
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis.

Authors:  Kazue Takahashi; Judith Gordon; Hong Liu; Kedarnath N Sastry; Judy E Epstein; Monica Motwani; Inga Laursen; Steffen Thiel; Jens Christain Jensenius; Michael Carroll; R Alan B Ezekowitz
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

View more
  14 in total

1.  C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.

Authors:  Dilip Shah; Freddy Romero; Ying Zhu; Michelle Duong; Jianxin Sun; Kenneth Walsh; Ross Summer
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

2.  Adipsin is an adipokine that improves β cell function in diabetes.

Authors:  James C Lo; Sanda Ljubicic; Barbara Leibiger; Matthias Kern; Ingo B Leibiger; Tilo Moede; Molly E Kelly; Diti Chatterjee Bhowmick; Incoronata Murano; Paul Cohen; Alexander S Banks; Melin J Khandekar; Arne Dietrich; Jeffrey S Flier; Saverio Cinti; Matthias Blüher; Nika N Danial; Per-Olof Berggren; Bruce M Spiegelman
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

Review 3.  Regulation of the gut microbiota by the mucosal immune system in mice.

Authors:  Mizuho Hasegawa; Naohiro Inohara
Journal:  Int Immunol       Date:  2014-05-02       Impact factor: 4.823

4.  Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis.

Authors:  Lin Zou; Yan Feng; Yan Li; Ming Zhang; Chan Chen; Jiayan Cai; Yu Gong; Larry Wang; Joshua M Thurman; Xiaobo Wu; John P Atkinson; Wei Chao
Journal:  J Immunol       Date:  2013-10-23       Impact factor: 5.422

5.  Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis.

Authors:  Jennifer Schepp-Berglind; Carl Atkinson; Michelle Elvington; Fei Qiao; Peter Mannon; Stephen Tomlinson
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

6.  New insights for C5a and C5a receptors in sepsis.

Authors:  Chunguang Yan; Hongwei Gao
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

7.  OPSI threat in hematological patients.

Authors:  B Serio; L Pezzullo; V Giudice; R Fontana; S Annunziata; I Ferrara; R Rosamilio; C De Luca; M Rocco; N Montuori; C Selleri
Journal:  Transl Med UniSa       Date:  2013-05-06

8.  Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.

Authors:  Erika van der Maten; Saskia van Selm; Jeroen D Langereis; Hester J Bootsma; Fred J H van Opzeeland; Ronald de Groot; Marien I de Jonge; Michiel van der Flier
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 9.  Saponins as adipokines modulator: A possible therapeutic intervention for type 2 diabetes.

Authors:  Olusola Olalekan Elekofehinti; Oluwamodupe Cecilia Ejelonu; Jean Paul Kamdem; Oluwaseun Benedicta Akinlosotu; Isaac Gbadura Adanlawo
Journal:  World J Diabetes       Date:  2017-07-15

10.  Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock.

Authors:  Rainer König; Amol Kolte; Olaf Ahlers; Marcus Oswald; Veiko Krauss; Daniela Roell; Oliver Sommerfeld; George Dimopoulos; Iraklis Tsangaris; Eleni Antoniadou; Neeraja Jaishankar; Holger Bogatsch; Markus Löffler; Markus Rödel; Marina Garcia-Moreno; Lorena Tuchscherr; Charles L Sprung; Mervyn Singer; Frank Brunkhorst; Michael Oppert; Herwig Gerlach; Ralf A Claus; Sina M Coldewey; Josef Briegel; Evangelos J Giamarellos-Bourboulis; Didier Keh; Michael Bauer
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.